‐Blocking IL‐4 signaling by anti‐IL‐4R delayed tumor growth.‐Prevention of cholesterol efflux by genetic deletion of ABC membrane cholesterol efflux transporters delayed tumor growth. This evidence concerns the gene IL4R and neoplasm.